J C Cappelleri

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. doi request reprint Evaluating the Power of Food Scale in obese subjects and a general sample of individuals: development and measurement properties
    J C Cappelleri
    Global Research and Development, Pfizer Inc, New London, CT 06320, USA
    Int J Obes (Lond) 33:913-22. 2009
  2. doi request reprint Psychometric analysis of the Three-Factor Eating Questionnaire-R21: results from a large diverse sample of obese and non-obese participants
    J C Cappelleri
    Pfizer Inc, Global Research and Development, New London, CT 06320, USA
    Int J Obes (Lond) 33:611-20. 2009
  3. ncbi request reprint Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes
    J C Cappelleri
    Pfizer Inc, Global Research and Development, Groton, Connecticut 06340, USA
    Diabetes Care 23:1799-803. 2000
  4. ncbi request reprint Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity
    J C Cappelleri
    Pfizer Inc, 445 Eastern Point Road, MS 8260 2502, Groton, CT, 06340, USA
    Qual Life Res 22:2489-99. 2013
  5. doi request reprint Evaluation of the fibromyalgia impact questionnaire at baseline as a predictor for time to pain improvement in two clinical trials of pregabalin
    A G Bushmakin
    Pfizer Inc, Statistics, Groton, CT, USA
    Int J Clin Pract 67:52-9. 2013
  6. ncbi request reprint Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial
    R A Gerber
    Pfizer Inc, Global Research and Development, Eastern Point Road, Groton, CT 06340, USA
    Diabetes Care 24:1556-9. 2001

Collaborators

Detail Information

Publications6

  1. doi request reprint Evaluating the Power of Food Scale in obese subjects and a general sample of individuals: development and measurement properties
    J C Cappelleri
    Global Research and Development, Pfizer Inc, New London, CT 06320, USA
    Int J Obes (Lond) 33:913-22. 2009
    ..The Power of Food Scale (PFS) was developed to assess the psychological impact of today's food-abundant environments...
  2. doi request reprint Psychometric analysis of the Three-Factor Eating Questionnaire-R21: results from a large diverse sample of obese and non-obese participants
    J C Cappelleri
    Pfizer Inc, Global Research and Development, New London, CT 06320, USA
    Int J Obes (Lond) 33:611-20. 2009
    ..The 21-item Three-Factor Eating Questionnaire (TFEQ-R21) is a scale that measures three domains of eating behavior: cognitive restraint (CR), uncontrolled eating (UE) and emotional eating (EE)...
  3. ncbi request reprint Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes
    J C Cappelleri
    Pfizer Inc, Global Research and Development, Groton, Connecticut 06340, USA
    Diabetes Care 23:1799-803. 2000
    ....
  4. ncbi request reprint Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity
    J C Cappelleri
    Pfizer Inc, 445 Eastern Point Road, MS 8260 2502, Groton, CT, 06340, USA
    Qual Life Res 22:2489-99. 2013
    ..The Physician Global Assessment (PGA) is a key measure of psoriasis frequently used in clinical trials. A psychometric validation of a three-item (erythema, induration, and scaling) PGA scale was performed using Phase 2 data...
  5. doi request reprint Evaluation of the fibromyalgia impact questionnaire at baseline as a predictor for time to pain improvement in two clinical trials of pregabalin
    A G Bushmakin
    Pfizer Inc, Statistics, Groton, CT, USA
    Int J Clin Pract 67:52-9. 2013
    ..This study evaluated the relationships between the functional status of FM patients, measured with the FIQ at baseline, and median time to a clinically relevant pain reduction...
  6. ncbi request reprint Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial
    R A Gerber
    Pfizer Inc, Global Research and Development, Eastern Point Road, Groton, CT 06340, USA
    Diabetes Care 24:1556-9. 2001
    ..Our objective was to compare patient satisfaction between inhaled insulin and subcutaneous insulin...